Lobbying reported · Sims Strategies (on Behalf Of Creighton University) · Jul 21Sims Strategies (on Behalf Of Creighton University) reported 2nd Quarter (Apr 1 - June 30) lobbying for US Physician Partners (informal Coalition) — $80,000BillsH.R. 1H.R. 4710S. 891
Lobbying reported · Sims Strategies (on Behalf Of Creighton University) · Jul 21Sims Strategies (on Behalf Of Creighton University) reported 2nd Quarter (Apr 1 - June 30) lobbying for Advion — $50,000BillsH.R. 1614H.R. 2477H.R. 3514H.R. 4206S. 891S. 1168S. 1261S. 1816
Lobbying reported · EMD Serono · Jul 21EMD Serono reported 2nd Quarter (Apr 1 - June 30) lobbying for EMD Serono — $700,000BillsH.R. 1H.R. 220H.R. 1492H.R. 3838H.R. 4317H.R. 6703H.R. 6797H.R. 8800S. 832S. 864S. 882S. 891S. 1071S. 2296S. 3345
Lobbying reported · Viatris · Jul 21Viatris reported 2nd Quarter (Apr 1 - June 30) lobbying for Viatris — $360,000BillsS. 891S. 2296S. 2658S. 3841
Lobbying reported · Forbes-Tate · Jul 20Forbes-Tate reported 2nd Quarter (Apr 1 - June 30) lobbying for American College Of Radiology Association — $50,000BillsS. 891
Lobbying reported · Forbes-Tate · Jul 20Forbes-Tate reported 2nd Quarter (Apr 1 - June 30) lobbying for Independent Pharmacy Cooperative — $40,000BillsH.R. 3164H.R. 4317S. 891S. 927S. 2426S. 3822
Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000BillsH.R. 1H.R. 247H.R. 379H.R. 584H.R. 608H.R. 610H.R. 842H.R. 935H.R. 950H.R. 957H.R. 1096H.R. 1117H.R. 1157H.R. 1162H.R. 1397H.R. 1403H.R. 1523H.R. 1614H.R. 1627H.R. 1775H.R. 1776H.R. 1805H.R. 1867H.R. 1899H.R. 1924H.R. 2013H.R. 2045H.R. 2049H.R. 2079H.R. 2199H.R. 2309H.R. 2433H.R. 2450H.R. 2528H.R. 2533H.R. 2553H.R. 2554H.R. 2571H.R. 2586H.R. 2610H.R. 2636H.R. 2741H.R. 3000H.R. 3023H.R. 3069H.R. 3415H.R. 3493H.R. 3527H.R. 3546H.R. 3701H.R. 3789H.R. 3808H.R. 4093H.R. 4206H.R. 4231H.R. 4313H.R. 4317H.R. 4406H.R. 4559H.R. 4605H.R. 4623H.R. 4641H.R. 4710H.R. 5081H.R. 5145H.R. 5243H.R. 5281H.R. 5371H.R. 5509H.R. 5526H.R. 5582H.R. 5584H.R. 6010H.R. 6232H.R. 6248H.R. 6255H.R. 6361H.R. 6703H.R. 6951H.R. 6974H.R. 7023H.R. 7064H.R. 7164H.R. 7189H.R. 7409H.R. 7537H.R. 7727H.R. 7778H.R. 7787H.R. 7790H.R. 7803H.R. 7837H.R. 7871H.R. 8270H.R. 8375H.R. 8377H.R. 8684H.R. 8779H.R. 8875H.R. 9393H.R. 9504S. 339S. 483S. 526S. 529S. 652S. 717S. 729S. 752S. 864S. 882S. 891S. 931S. 939S. 976S. 1040S. 1056S. 1082S. 1096S. 1227S. 1261S. 1637S. 1753S. 1816S. 1818S. 1847S. 1954S. 1973S. 2237S. 2289S. 2345S. 2355S. 2356S. 2497S. 2556S. 2620S. 2658S. 2709S. 2903S. 3014S. 3599S. 3642S. 3690S. 3727S. 3729S. 3750S. 3751S. 3762S. 3822S. 3829S. 3834S. 3848S. 3886S. 3990S. 4189S. 4332S. 4355S. 4384S. 4509S. 4512
Lobbying reported · Carol G Holladay & Associates · Jul 20Carol G Holladay & Associates reported 2nd Quarter (Apr 1 - June 30) lobbying for Southeast Georgia Hospital System — $24,000BillsH.R. 1266H.R. 1561H.R. 2004H.R. 3514H.R. 5081H.R. 5243H.R. 5880H.R. 6240H.R. 6468H.R. 7184H.R. 7970H.R. 7994H.R. 8005H.R. 8201H.R. 9389H.R. 9390H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 526S. 527S. 891S. 927S. 2709S. 3206S. 3345
Lobbying reported · Cambia Health Solutions · Jul 20Cambia Health Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Cambia Health Solutions — $700,000BillsH.R. 247H.R. 2079H.R. 3417H.R. 3514H.R. 4206H.R. 4710H.R. 5243H.R. 5746H.R. 6703H.R. 7149H.R. 7895H.R. 8375H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 882S. 891S. 976S. 1040S. 1096S. 1261S. 1954S. 2355S. 3345
Lobbying reported · American Medical Association · Jul 20American Medical Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Medical Association — $5,130,000BillsH.Con.Res. 14H.R. 1H.R. 2H.R. 483H.R. 539H.R. 628H.R. 929H.R. 1201H.R. 1266H.R. 1317H.R. 1520H.R. 1561H.R. 1585H.R. 1614H.R. 1968H.R. 2004H.R. 2028H.R. 2120H.R. 2191H.R. 2234H.R. 2314H.R. 2332H.R. 2433H.R. 2483H.R. 2757H.R. 2767H.R. 2794H.R. 2850H.R. 2902H.R. 3069H.R. 3108H.R. 3164H.R. 3170H.R. 3514H.R. 3878H.R. 3890H.R. 4002H.R. 4074H.R. 4206H.R. 4541H.R. 4583H.R. 4681H.R. 4710H.R. 4731H.R. 4837H.R. 4977H.R. 5081H.R. 5178H.R. 5199H.R. 5281H.R. 5283H.R. 5347H.R. 5940H.R. 6100H.R. 6160H.R. 6280H.R. 6468H.R. 6994H.R. 7023H.R. 7148H.R. 7520H.R. 7868H.R. 7884H.R. 7905H.R. 7961H.R. 7970H.R. 7994H.R. 8031H.R. 8129H.R. 8163H.R. 8201H.R. 8209H.R. 8261H.R. 8335H.R. 8375H.R. 8413H.R. 8487H.R. 8500H.R. 8622H.R. 8794H.R. 8823H.R. 8890H.R. 8915H.R. 9058H.R. 9192H.R. 9237H.R. 9393H.R. 9396H.R. 9504S. 106S. 266S. 526S. 527S. 665S. 709S. 891S. 942S. 1031S. 1140S. 1261S. 1330S. 1367S. 1380S. 1460S. 1552S. 1782S. 1816S. 1996S. 2426S. 2709S. 2759S. 3315S. 3480S. 3599S. 3607S. 3750S. 3762S. 3822S. 4070S. 4384S. 4591S. 4637S. 4916
Lobbying reported · American Medical Association · Jul 20American Medical Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Medical Association — $513,000BillsH.Con.Res. 14H.R. 1H.R. 2H.R. 483H.R. 539H.R. 628H.R. 929H.R. 1201H.R. 1266H.R. 1317H.R. 1520H.R. 1561H.R. 1585H.R. 1614H.R. 1968H.R. 2004H.R. 2028H.R. 2120H.R. 2191H.R. 2234H.R. 2314H.R. 2332H.R. 2433H.R. 2483H.R. 2757H.R. 2767H.R. 2794H.R. 2850H.R. 2902H.R. 3069H.R. 3108H.R. 3164H.R. 3170H.R. 3514H.R. 3878H.R. 3890H.R. 4002H.R. 4074H.R. 4206H.R. 4541H.R. 4583H.R. 4681H.R. 4710H.R. 4731H.R. 4837H.R. 4977H.R. 5081H.R. 5178H.R. 5199H.R. 5281H.R. 5283H.R. 5347H.R. 5940H.R. 6100H.R. 6160H.R. 6280H.R. 6468H.R. 6994H.R. 7023H.R. 7148H.R. 7520H.R. 7868H.R. 7884H.R. 7905H.R. 7961H.R. 7970H.R. 7994H.R. 8031H.R. 8129H.R. 8163H.R. 8201H.R. 8209H.R. 8261H.R. 8335H.R. 8375H.R. 8413H.R. 8487H.R. 8500H.R. 8622H.R. 8794H.R. 8823H.R. 8890H.R. 8915H.R. 9058H.R. 9192H.R. 9237H.R. 9393H.R. 9396H.R. 9504S. 106S. 266S. 526S. 527S. 665S. 709S. 891S. 942S. 1031S. 1140S. 1261S. 1330S. 1367S. 1380S. 1460S. 1552S. 1782S. 1816S. 1996S. 2426S. 2709S. 2759S. 3315S. 3480S. 3599S. 3607S. 3750S. 3762S. 3822S. 4070S. 4384S. 4591S. 4637S. 4916
Lobbying reported · Crossroads Strategies · Jul 20Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Sanofi US Services — $50,000BillsH.R. 1H.R. 8800H.R. 9260S. 891S. 4784
Lobbying reported · Crossroads Strategies · Jul 18Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $50,000BillsH.R. 1492H.R. 8646H.R. 8800H.R. 9260S. 527S. 832S. 891S. 1040S. 1096S. 2658S. 3014S. 4784
Lobbying reported · Crossroads Strategies · Jul 18Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Takeda Pharmaceuticals America — $50,000BillsH.R. 1S. 891
Lobbying reported · National Community Pharmacists Association · Jul 17National Community Pharmacists Association reported 2nd Quarter (Apr 1 - June 30) lobbying for National Community Pharmacists Association — $270,000BillsH.Con.Res. 14H.R. 1H.R. 1968H.R. 3164H.R. 4317H.R. 4409H.R. 5031H.R. 5133H.R. 5304H.R. 5316H.R. 6400H.R. 6509H.R. 6609H.R. 6610H.R. 6703H.R. 6837H.R. 7148H.R. 7895H.R. 8269H.R. 8779H.R. 8800S. 526S. 527S. 882S. 891S. 927S. 1941S. 2426S. 3159S. 3345S. 3549S. 3788S. 3794S. 3822S. 4106S. 4509S. 4784S.Con.Res. 7
Lobbying reported · Crossroads Strategies · Jul 17Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Merck & — $40,000BillsH.R. 1H.R. 8800S. 891S. 4784
Lobbying reported · Capitol Counsel · Jul 16Capitol Counsel reported 2nd Quarter (Apr 1 - June 30) lobbying for American Academy of Ophthalmology — $30,000BillsH.R. 1H.R. 8163S. 891
Lobbying reported · Capitol Counsel · Jul 16Capitol Counsel reported 2nd Quarter (Apr 1 - June 30) lobbying for American Academy Of Dermatology — $40,000BillsH.R. 1H.R. 8163S. 891
Lobbying reported · Glaxosmithkline · Jul 16Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1071S. 1096S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Crossroads Strategies · Jul 16Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Eisai — $50,000BillsH.R. 1H.R. 8800S. 891S. 4784